ORIC-1940

N/A

Report date: 2025/02/24 13:24:22
NME

Base Information

Drug NameORIC-1940
Drug Alias NameORIC-1940ORIC1940
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsLymphohistiocytosis, Hemophagocytic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Aorui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Aorui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphohistiocytosis, Hemophagocytic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A